Rooted in decades of innovation, expertise, and reliability,Bio-Synthesis, a premier US-based CRO/CDMO company has grown from a pioneering oligonucleotide manufacturer into a comprehensive synthetic biology and genomics solutions provider with over 40 years of industry leadership.
Since 1984 we have collaborated closely with scientists, healthcare innovators, and industry leaders to enable scalable breakthroughs in therapeutics, diagnostics, and global health. As part of our commitment to excellence, we continually invest in our state-of-the-art DNA synthesis platforms, bioconjugation technologies, and cGMP-compliant operations.Our vision is clear: to empower researchers and developers to translate discoveries into life-changing outcomes,shaping a healthier and brighter future for all.
We bring together cutting-edge synthetic biology capabilities with stringent quality control systems, ensuring that every product meets the highest scientific and regulatory standards.
With extensive scale-up expertise and a strong track record in RNA-based therapeutics, Bio-Synthesis helps transition innovative programs from discovery through clinical development. We collaborate with multinational biotech and pharmaceutical companies, offering solutions that accelerate therapeutic, vaccine, diagnostic, and biopharmaceutical breakthroughs.
We operate under a robust Quality Management System aligned with:
Purpose-built to meet the dynamic needs of our valued customers, our fully integrated site manages everything—from production to packaging and shipping—under one roof. This streamlined approach ensures unmatched quality, operational efficiency, and rapid delivery at every stage.
Trusted by biotech leaders worldwide for over 40+ years of delivering high quality, fast and scalable synthetic biology solutions.
